SB273005 is a potent, orally bioavailable small molecule antagonist of integrins alphavbeta3 and alphavbeta5. It has demonstrated in vivo efficacy in murine pregnancy models by suppressing Th2 cell differentiation and IL-10 cytokine production, supporting its research use in immunology and reproductive studies.